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Adipokinetic hormone (AKH), corazonin (CRZ), and the AKH/CRZ-related peptide (ACP)
are neuropeptides considered homologous to the vertebrate gonadotropin-releasing
hormone (GnRH). All three Aedes aegypti GnRH-related neuropeptide receptors have
been characterized and functionally deorphanized. Individually they exhibit high specificity
for their native ligands, prompting us to investigate the contribution of ligand structures
in conferring receptor specificity for two of these receptors. Here, we designed a series
of analogs based on the native ACP sequence and screened them using a heterologous
system to identify critical residues required for ACP receptor (ACPR) activation. Analogs
lacking the carboxy-terminal amidation, replacing aromatics, as well as truncated analogs
were either completely inactive or had very low activities on ACPR. The polar threonine
(position 3) and the blocked amino-terminal pyroglutamate are also critical, whereas
ACP analogs with alanine substitutions at position 2 (valine), 5 (serine), 6 (arginine),
and 7 (aspartate) were less detrimental including the substitution of charged residues.
Replacing asparagine (position 9) with an alanine resulted in a 5-fold more active
analog. A naturally-occurring ACP analog, with a conserved substitution in position two,
was well tolerated yet displayed significantly reduced activity compared to the native
mosquito ACP peptide. Chain length contributes to ligand selectivity in this system,
since the endogenous octapeptide Aedae-AKH does not activate the ACPR whereas
AKH decapeptides show low albeit significant activity. Similarly, we utilized this in vitro
heterologous assay approach against an A. aegypti AKH receptor (AKHR-IA) testing
carefully selected naturally-occurring AKH analogs from other insects to determine how
substitutions of specific residues in the AKH ligand influence AKHR-IA activation. AKH
analogs having single substitutions compared to Aedae-AKH revealed position 7 (either
serine or asparagine) was well tolerated or had slightly improved activation whereas
changes to position 6 (proline) compromised receptor activation by nearly 10-fold.
Substitution of position 3 (threonine) or analogs with combinations of substitutions
were quite detrimental with a significant decrease in AKHR-IA activation. Collectively,
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these results advance our understanding of how two GnRH-related systems in A.
aegypti sharing the most recent evolutionary origin sustain independence of function
and signaling despite their relatively high degree of ligand and receptor homology.
Keywords: GnRH-related neuropeptides, G protein-coupled receptor, structure activity relationships, adipokinetic
hormone (AKH), corazonin (CRZ), AKH/CRZ-related peptide (ACP)
INTRODUCTION
In invertebrates there exist three neuropeptide systems of which
the mature peptides as well as their cognate G protein-coupled
receptors (GPCRs) are structurally similar, and collectively,
they are related to the vertebrate gonadotropin releasing
hormone (GnRH) system and suggested to form a large
peptide superfamily (1–4). These neuropeptide systems are called
the adipokinetic hormone (AKH)/red pigment-concentrating
hormone (RPCH) family, the corazonin (CRZ) family, and
the structurally intermediate adipokinetic hormone/corazonin-
related peptide (ACP) family. AKHs are primarily or exclusively
produced in neurosecretory cells of the corpus cardiacum, and
a major function is mobilization of energy reserves stored in
the fat body, thus providing an increase of the concentration of
diacylglycerols, trehalose, or proline for locomotory active phases
in the haemolymph. In accordance with this function, AKH
has been shown to activate the enzymes glycogen phosphorylase
and triacylglycerol lipase and transcripts of the AKHR are most
prominently found in fat body tissue [see reviews by (5–7)]. As
with most endocrine regulatory peptides, additional functions
such as inhibition of anabolic processes (protein and lipid
syntheses), involvement in oxidative stress reactions and egg
production inter alia are known making AKH a truly pleiotropic
hormone [see reviews by (8, 9)]. This is also true for CRZ which
is mainly synthesized in neuroendocrine cells of the pars lateralis
of the protocerebrum and released via the corpora cardiaca
(10). Although originally described as a potent cardiostimulatory
peptide (11), it does not generally fulfill this role but is known for
many additional functions such as involvement in the (i) release
of pre-ecdysis and ecdysis triggering hormones, (ii) reduction
of silk spinning rates in the silk moth, (iii) pigmentation events
(darkening) of the epidermis in locusts during gregarization and
(iv) regulation of caste identity in an ant species (12–15). The
functional role of ACP is less clear. All previous studies had
not found a clear-cut function for this peptide until work by
Zhou and colleagues claimed that ACP in the cricket Gryllus
bimaculatus regulates the concentration of carbohydrates and
lipids in the haemolymph (16).
Experiments in the current study have been conducted with
the mosquito species Aedes aegypti for a number of reasons.
Firstly, A. aegypti is an infamous disease vector for pathogens
such as Yellow and Dengue fever, Chikungunya and, as latest
addition, Zika arboviruses; summarily these are responsible for
affecting approximately 50–100 million people per year (17–
19). Secondly, knowledge on the interaction of the ligands with
their respective receptor are thought to be very helpful for drug
research using specific GPCRs as targets for development of
selective biorational insecticides (20–22). Another reason was
that each of the three neuropeptide systems has already been
partially investigated, thus, this study could build on previous
research data. With respect to the peptides, these were first
predicted from the genomic work on A. aegypti (23). The
presence of mature AKH and corazonin, but not of ACP,
was shown by direct mass profiling (24). The AKH and ACP
precursors have been cloned (25) as have one CRZ receptor
(CRZR) and multiple transcript variants of the AKHR and
ACPR (25–27). Each receptor is very selective and responds only
to its cognate peptide, thus there are indeed three completely
separate and independently working neuroendocrine systems
active in this mosquito species. Here, we hone in on two of these
systems, specifically ACP/ACPR and AKH/AKHR, which share
the closest evolutionary relationship (2, 28–30), and examined
structural features of each ligand important for conferring
receptor specificity and activation.
With respect to the ACP system in A. aegypti, expression
studies revealed transcripts of the major ACPR form as well as
the ACP precursor were enriched during development in adults,
specifically during day one and four after eclosion (25, 27). On
the tissue level, ACP precursor transcripts are mainly present in
the head/thorax region (25) and, more specifically, within the
brain and thoracic ganglia (27) and the ACPR transcripts are
mainly detected in the central nervous system with significant
enrichment in the abdominal ganglia, particularly in males (27).
The AKH precursor transcripts are present in head/thorax region
of pupae and adult females and in the abdomen of males (25).
Expression of AKHR was shown in all life stages (25), but similar
to the ACPR andACP transcripts, AKHR transcript variants were
found to be significantly enriched in early adult stages (26). On
the tissue level, highest expression in adults was found in thorax
and abdomen with low levels detected in ovaries (25). Similar
expression profiles were determined recently by Oryan et al. (26)
using RT-qPCR: expression in head, thoracic ganglia, accessory
reproductive tissues, and carcass of adult females as well as in
abdominal ganglia and specific enrichment in the carcass and
reproductive organs of adult males.
Thus, although quite a substantial body of information on
the three signaling systems in A. aegypti is known, we lack
knowledge of how the various ligands interact with their cognate
receptor. For instance, which amino acid residue in the ligand
is specifically important for this interaction? By replacing each
residue successively with simple amino acids such as glycine or
alanine one can probe into the importance of amino acid side
chains and their characteristics in relation to facilitating receptor
specificity. Such structure-activity studies have been conducted
on the AKH system in a number of insects and a crustacean either
by measuring physiological actions in vivo (31, 32) or in a cellular
mammalian expression system in vitro (33–35). In conjunction
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with nuclear magnetic resonance (NMR) data on the secondary
structure of AKHs (36, 37) and the knowledge of the receptor
sequence, molecular dynamic methods can devise models how
the ligand is interacting with its receptor (38, 39). Such a
comprehensive study carried out recently on the locust AKH
receptor demonstrated that all three endogenous AKH peptides,
including two octa- and one decapeptide, interact with similar
residues and share the same binding site on their receptor (40).
Since no such data is available for any ACP system, the
objective of the current study was to fill this knowledge gap
by determining critical amino acids of the ACP neuropeptide
necessary for activation of its cognate receptor, ACPR. We
therefore designed a series of analogs based on the endogenous
A. aegypti ACP sequence and screened them using an in vitro
receptor assay system to determine the crucial residues for
ACPR activation. Given the closer evolutionary relationship
between the ACP and AKH systems in arthropods (2, 28–
30), a second aim of the current study was to advance our
knowledge and understanding of critical residues and properties
of uniquely positioned amino acids necessary for the specificity
of the AKH ligand to its receptor, AKHR-IA. Given the
extensive earlier studies examining AKH structure activity
relationships, which established that aromatics at positions 4
and 8 and blocked N- and C-terminal ends are critical, we
took advantage of naturally occurring AKHs from other insects
to examine other positions with amino acid substitutions and
determine the consequences onto AKHR-IA activation using
the same in vitro heterologous assay. Collectively, determining
indispensable amino acid residues of these two GnRH-related
mosquito neuropeptides that are necessary for activation of their
prospective receptors will help clarify how these evolutionarily-
related systems uphold specific signaling networks avoiding cross
activation onto the structurally related, but functionally distinct
signaling system.
MATERIALS AND METHODS
ACP and AKH Receptor Expression
Construct Preparation
A mammalian expression construct containing the ACPR-
I ORF (hereafter denoted as ACPR) with Kozak translation
initiation sequence had been previously prepared in pcDNA3.1+
(27); however, this earlier study revealed that coupling of the
ACPR with calcium mobilization in the heterologous expression
system was not very strong, even following application of
high concentrations of the native ACP ligand. Therefore,
to improve the bioluminescent signal linked to calcium
mobilization following receptor activation, which was required
in order to provide greater signal to noise ratio when testing
ACP analogs with substitutions leading to intermediate levels
of activation of the ACPR, we created a new mammalian
expression construct using the dual promoter vector, pBudCE4.1.
Specifically, we utilized a cloning strategy as reported previously
(41) whereby the ACPR was inserted into the multiple cloning
site (MCS) downstream of the CMV promoter in pBudCE4.1
using the sense primer SalI-KozakACPR, 5′-GGTCGACGCCAC
CATGTATCTTTCGG-3′ and anti-sense primer XbaI-ACPR, 5′-
TCTAGATTATCATCGCCAGCCACC-3′, which directionally
inserted the ACPR within the MCS downstream of the CMV
promoter. Secondly, the murine homolog (Gα15) of the
human promiscuous G protein, Gα16, which indiscriminately
couples a wide variety of GPCRs to calcium signaling
(42) was inserted into the MCS downstream of the EF1-α
promoter in pBudCE4.1 using the sense primer NotI-Gα15,
5′-GCGGCCGCCACCATGGCCCGGTCCCTGAC-3′ and anti-
sense primer BglII-Gα15, 5′-AGATCTTCACAGCAGGTTGA
TCTCGTCCAG-3′, which directionally inserted the murine
Gα15 within the MCS downstream of the EF1-α promoter.
The AKHR mammalian expression construct used in the
current study, specifically AKHR-IA which was the receptor
isoform that exhibited the greatest sensitivity to its native AKH
ligand, was prepared previously in pcDNA3.1+ (26) and coupled
strongly with calcium signaling in the heterologous system so
there was no need utilize the dual promoter vector containing
the promiscuous Gα15 as was necessary for ACPR. For each
construct, an overnight liquid culture of clonal recombinant
bacteria containing the appropriate plasmid construct was grown
in antibiotic-containing LB media and used to isolate midiprep
DNA using the PureLink Midiprep kit (Life Technologies,
Burlington, ON). Midiprep samples were then quantified and
sent for sequencing as described previously (26, 27).
Cell Culture, Transfections, and Calcium
Bioluminescence Reporter Assay
Functional activation of the AedaeACPR and AedaeAKHR-IA
receptors was carried out following a previously described
mammalian cell culture system involving a Chinese hamster
ovary (CHO)-K1 cell line stably expressing aequorin (43).
Cells were grown in DMEM:F12 media containing 10%
heat-inactivated fetal bovine serum (Wisent, St. Bruno,
QC), 200µg/mL Geneticin, 1x antimycotic-antibiotic
to approximately 90% confluency, and were transiently
transfected using either Lipofectamine LTX with Plus Reagent
or Lipofectamine 3000 transfection systems (Invitrogen,
Burlington, ON) following manufacturer recommended DNA to
transfection reagent ratios. Cells were detached from the culture
flasks at 48 h post-transfection using 5mM EDTA in Dulbecco’s
PBS. Cells were then prepared for the receptor functional assay
following a procedure described previously (27). Stocks of
peptide analogs of ACP and AKH were used for preparation of
serial dilutions all of which were prepared in assay media (0.1%
BSA in DMEM:F12) and loaded in quadruplicates into 96-well
white luminescence plates (Greiner Bio-One, Germany). Cells
were loaded with an automatic injector into each well of the plate
containing different peptide analogs at various concentrations
as well as negative control (assay media alone) and positive
control wells (50µM ATP). Immediately after injection of the
cells, luminescence was measured for 20 s using a Synergy 2
Multi-Mode Microplate Reader (BioTek, Winooski, VT, USA).
Calculations, including determination of EC50 values, were
conducted in GraphPad Prism 7.02 (GraphPad Software, San
Diego, USA) from dose-response curves from 3 to 4 independent
biological replicates.
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TABLE 1 | Primary structure of the synthetic ACP analogs designed, a natural
ACP analog along with extended AKH decapeptides that were tested on the A.
aegypti ACP receptor (AedaeACPR).
Peptide/
Analog
Primary structure
of analog
Activity on A.
aegypti ACPR
(EC50)
Fold-reduction
in activity
relative to
AedaeACP
Aedae-ACP pQVTFSRDWNAamide 2.394E−08 –
Aedae-ACP (A1) AVTFSRDWNAamide 1.576E−06 411.1
Aedae-ACP (A2) pQATFSRDWNAamide 7.052E−07 69.8
Aedae-ACP (A3) pQVAFSRDWNAamide 2.26E−05 550.8
Aedae-ACP (A4) pQVTASRDWNAamide ND >1,000
Aedae-ACP (A5) pQVTFARDWNAamide 1.038E-06 44.9
Aedae-ACP (A6) pQVTFSADWNAamide 6.872E−07 23.3
Aedae-ACP (A7) pQVTFSRAWNAamide 3.863E−07 15.9
Aedae-ACP (A8) pQVTFSRDANAamide ND >1,000
Aedae-ACP (A9) pQVTFSRDWAAamide 4.96E−09 0.2
Aedae-ACP (-OH) pQVTFSRDWNA-OH ND >1,000
Aedae-ACP (A1b) Acetyl-AVTFSRDWNAamide 5.272E−07 43.6
Aedae-ACP (1-9) pQVTFSRDWN-amide 4.153E−06 434.2
Aedae-ACP (1-8) pQVTFSRDW–amide 2.156E−06 410.1
Aedae-ACP
(1,3-10)
pQ-TFSRDWNAamide ND >1,000
Aedae-ACP (+G) pQVTFSRDWNAGamide 1.113E−07 5.6
Grybi-ACP pQITFSRDWNAamide 3.255E−07 13.6
Bommo-AKH pQLTFTPGWGQamide ND >1,000
Lacol-AKH pQLTFTSSWGGamide ND >1,000
Helze-AKH pQLTFSSGWGNamide ND >1,000
Using heterologous expression of ACPR, the half maximal effective concentration for
each of the analogs was determined as well as the corresponding reduction in activity,
highlighting how a particular residue substitution or other modification is tolerated in this
system. ND = represents no determined EC50 value due to minimal or no detectable
activity of the analog when tested up to 10 µM.
Synthetic Peptides and Analogs
Peptide analogs based on the native ACP sequence were designed
and synthesized by Pepmic Co., Ltd. (Suzhou, China) at a purity
of over 90%. All synthetic peptides were initially prepared as
stock solutions at a concentration of 1mM in dimethyl sulfoxide.
All stocks of arthropod AKH analogs were prepared similarly
to the ACP synthetic peptide analogs and were commercially
synthesized by either Pepmic Co., Ltd. (Suzhou, China) or by
Synpeptide Co. (Shanghai, China) at a purity of over 90% verified
by HPLC and mass spectrometry. Specific sequence information
for each of the peptides (and analogs) used on the ACP and
AKH receptors examined in this study are provided in Tables 1,
2, respectively.
RESULTS
ACP Synthetic Analog Activity on Mosquito
ACPR
Analogs of native ACP with single alanine substitutions at
each amino acid were synthesized and evaluated by examining
their functional activation of the A. aegypti ACP receptor
(ACPR) expressed using a heterologous system. Carboxy-
terminal amidation of ACPwas found to be critical for bioactivity
as were the two aromatic residues of ACP, including the
phenylalanine in the fourth position or tryptophan in the
eighth position, since analogs modifying these key features
demonstrated no activation of ACPR up to the highest tested
concentration of 10µM (Figure 1A, Table 1). Analysis of single
residue alanine substitutions revealed that the next most critical
residues for retaining ACPR functional activation were the polar
threonine in position three and the blocked pyroglutamate
(pGlu) at the amino terminus, which upon replacement with
alanine resulted in a ∼551- and ∼411-fold reduced activity,
respectively, compared to native ACP (Figure 1A, Table 1).
Alternative blocking of the amino terminus, using N-Acetyl-
alanine instead of pGlu, revealed this analog was 10-times more
active than the non-blocked one, having only ∼44-fold reduced
activity compared to native ACP (Figure 1A). Substitutions with
analogs containing alanine at the second (valine), fifth (serine),
sixth (arginine), and seventh (aspartic acid) positions, had
noticeably less impact on the reduction of activity (Figure 1B),
by ∼70, ∼45, ∼23, and ∼16-fold, respectively. The analog
containing an alanine substitution for the asparagine in position
nine resulted in a more potent ACPR activation, leading to a
∼5-fold greater activity compared to the native ACP peptide
(Figure 1B). C-terminally truncated analogs, which lacked either
the alanine residue in the tenth position alone or both asparagine
and alanine in positions nine and ten, were almost completely
inactive, demonstrating ∼434 and ∼410-fold reduced ACPR
activation compared to native ACP (Figure 1C). A C-terminally
extended analog, an undecapeptide (i.e., polypeptide with 11
amino acids residues), ending with a glycine amide on the
C-terminus elicited a small decrease of activity by about ∼6-
fold (Figure 1C). The internally truncated ACP analog lacking
a valine in the second position also was without any effect,
similar to the two aromatic residue substituted analogs or
the non-amidated ACP analog (Figure 1C). An ACP analog
from the cricket Gryllus bimaculatus (Grybi-ACP) was used
to further examine the importance of the second position
valine in Aedae-ACP, which is replaced by an isoleucine in G.
bimaculatus. Grybi-ACP was quite active compared to Aedae-
ACP but nonetheless demonstrated nearly ∼14-fold reduced
activity and failed to reach full ACPR activation even when
the highest concentration was tested (Figure 2A). As shown
previously, the endogenous octapeptide Aedae-AKH did not
activate the ACPR at all; however, a subset of the three naturally-
occurring insect AKH decapeptides tested here caused some
activation, albeit very weak with Lacol-AKH and Helze-AKH
leading to between 15 and 20% ACPR activation at the highest
tested concentrations (Figure 2B).
Activity of Natural Arthropod AKH Analogs
on Mosquito AKHR-IA
Taking advantage of the variety of natural AKH analogs in
arthropods, we examined a subset of insect AKH peptides (see
Table 2) with unique substitutions compared to the endogenous
mosquito AKH peptide and determined their activity on the
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TABLE 2 | Primary structure of select naturally occurring AKH analogs from insects and their activity on the A. aegypti AKHR-IA receptor (AKHR-IA).
Peptide/Analog Species origin Primary structure of
analog
Activity on A.
aegypti AKHR-IA
(EC50)
Fold-reduction in
activity relative to
Aedae-AKH
Aedae-AKH Aedes aegypti pQLTFTPSWamide 2.159E−09 –
Lacol-AKH-7mer *Laconobia oleracea pQLTFTSS-amide ND >10,000
Grybi-AKH Gryllus bimaculatus pQVNFSTGWamide 2.23E−06 1031.5
Libau-AKH Libellula auripennis pQVNFTPSWamide 1.18E−06 547.9
Pyrap-AKH Pyrrhocoris apterus pQLNFTPNWamide 7.269E−07 336.7
Erysi-AKH Erythemis simplicicollis pQLNFTPSWamide 6.69E−07 309.9
V2-PeramCAH-II *Periplaneta americana pQVTFTPNWamide 1.485E−07 68.8
Bommo-AKH Bombyx mori pQLTFTPGWGQamide 2.362E−08 10.9
Hipes-AKH-I Hippotion eson pQLTFTSSWamide 1.647E−08 7.6
Peram-CAH-II Periplaneta americana pQLTFTPNWamide 2.226E−09 1.0
Tabat-AKH Tabanus atratus pQLTFTPGWamide 1.522E−09 0.7
Using heterologous expression of AKHR-IA, the half maximal effective concentration for each of the analogs was determined as well as the corresponding reduction in activity, highlighting
how a particular single residue substitution, a combination of substitutions or other modifications are tolerated in this system. ND = represents no determined EC50 value due to minimal
or no detectable activity of the analog when tested up to 10 µM.
*Denotes a synthetic analog that is based on an endogenous peptide from this insect.
AKH receptor, A. aegypti AKHR-IA. From this analysis, the
least effective analog tested was the C-terminally truncated
peptide, Lacol-AKH-7mer, with only ∼7% AKHR-IA activation
at the highest tested concentration (10µM), which represents a
reduced efficacy of at least five orders of magnitude (Figure 3A).
The next least active AKH analog was the cricket peptide, Grybi-
AKH, which has five residues substituted over the length of
the octapeptide compared to Aedae-AKH (see Table 2), and the
activity of this analog on mosquito AKHR-IA is compromised by
over three orders of magnitude (1,032-fold reduced activity) as a
result of these combined substitutions (Table 2 and Figure 3A).
The AKH from the dragonfly, Libellula auripennis (Libau-AKH),
with substitutions at positions two and three only, had a nearly
2-fold improved activation over that achieved by Grybi-AKH;
however, the activity of this peptide on the A. aegypti AKHR-
IA was still reduced by 548-fold compared to Aedae-AKH
(Table 2). The AKH from the firebug Pyrrhocoris apterus (Pyrap-
AKH) that has two substitutions in positions three and seven,
both asparagine, is better tolerated than Libau-AKH and Grybi-
AKH but is still less active on the A. aegypti AKHR-IA being
compromised by 337-fold relative to Aedae-AKH (Figure 3A).
To better understand the importance of N-terminal residues, we
tested an AKH analog from the dragonfly Erythemis simplicicollis
(Erysi-AKH), which is only different to Aedae-AKH at position
three (threonine to asparagine; see Table 2); Erysi-AKH had
310-fold less activity compared to Aedae-AKH (Figure 3A). The
peptide named V2-Peram-CAH-II, which is a synthetic analog of
one of the two endogenous peptides of the American cockroach,
Periplaneta americana, does not occur in this species and is
characterized by a second position substitution of valine for
leucine along with the seventh position substitution of asparagine
for serine (seeTable 2). AKHR-IA activation by V2-Peram-CAH-
II was found much improved, albeit still 69-fold less effective
compared to the native A. aegypti AKH (Figure 3B). If the C-
terminus is extended by two amino acids as implemented by
utilizing the AKH analog from the domestic silkmoth, Bombyx
mori (Bommo-AKH), having glycine at position nine, glutamine
at position 10 and a glycine at position seven (instead of the serine
in Aedae-AKH), revealed activation of AKHR-IA was reduced
by only 11-fold (Figure 3B). Finally, examining natural analogs
of this peptide family containing single substitutions in the C-
terminal region, at positions six or seven, it was demonstrated
that these changes result in only a slight reduction of activation.
The cockroach AKH, Peram-CAH-II (seventh position serine
substituted with asparagine) had near identical efficacy to the
native mosquito AKH while the AKH analog from the sphingid
moth, Hippotion eson (Hipes-AKH-I; serine substitution for
proline in the sixth position), had only an 8-fold reduced
activity (Figure 3B). The AKH analog from the black horse fly,
Tabanus atratus (Tabat-AKH; glycine substitution for serine at
position seven), had an activation that partially exceeded (∼30%
improved efficacy) the activity of the native mosquito AKH (see
Table 2; Figure 3B).
DISCUSSION
The current study set out to examine for the first time the
ligand structure-activity relationship for an insect ACP receptor.
This is of utmost importance in order to gain insight on the
specific structural features of the ACP system given that extensive
studies have been carried out previously on AKH receptors in
a variety of species using natural and synthetic analogs of this
neuropeptide family (32, 33, 44–57). For comparative reasons,
we also studied the AKH receptor of A. aegypti but did not
examine all residues since a plethora of previous research had
clearly identified critical residues, for example the aromatics in
positions four and eight (see references above). By examining
the activity of a variety of ACP analogs on the activation of
the A. aegytpi ACP receptor (ACPR), including single alanine
substitutions along with truncated or extended analogs, a few
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FIGURE 1 | Dose–response curves of the native A. aegypti ACP along with
synthetic analogs that contain single substitutions or other modifications,
(Continued)
FIGURE 1 | which were tested for their activity on the ACP receptor (ACPR)
using a cell-based bioluminescent assay. (A) Single amino acid substitutions
with alanine or modifications to the normally blocked N- or C-termini resulting
in a significant reduction to their activity on the ACPR. (B) Single amino acid
substitutions with alanine to the native ACP sequence having minimal effects
to the activity of the tested analogs indicating these substitutions are well
tolerated. (C) Analogs with internal or terminal truncations or extension (i.e.,
+Gly analog) relative to the native ACP sequence conferring significant
reductions to their activity on the ACPR. The half maximal effective
concentration (EC50) for each analog along with the corresponding change in
activity relative to native A. aegypti ACP is provided in Table 1. Luminescence
is plotted relative to the maximal response achieved when 10−5M Aedae-ACP
was applied to the ACPR. Data represent mean +/− standard error of three
independent biological replicates.
observations can be highlighted. Firstly, the overall charge of
the peptide does not appear to play a role with regards to its
influence on receptor activation since substitution of the basic
(arginine) or acidic (aspartic acid) residues did not lead to a
highly detrimental effect. Specifically, one would assume that
the ACP receptor may prefer a neutral ligand given that the
native ACP has no net charge (i.e., is neutral) since it has
both a single basic and acidic residue. However, the modified
analogs which replace the basic (position 6) or acidic (position
7) residues with alanine, create negatively or positively charged
molecules, respectively, with both being quite active and so
neither proved to be detrimental substitutions, suggesting that
the extra carboxy- or amino group is not involved in forming
a salt bridge with the receptor. Secondly, with the exception of
the aromatic tryptophan residue in the eighth position, the C-
terminal residues of ACP do not appear to be highly important
since alanine substitutions in positions five through seven only
marginally impacted activity between ∼16 to 45-fold whereas
alanine substitution in position nine resulted in this analog
having 5-fold increased activity. Such a compound may be a
good lead substance for the development of a superagonist in
future studies, with the eventual goal to design an active non-
peptidergic mimetic. Amidation of the C-terminal residue was
critical since the free acid analog exhibited no activity; however, it
is noteworthy that the C-terminally extended peptide having an
amidated glycine was also quite effective with ACPR activation
compromised by only 6-fold. Previous studies examining free
acid analogs of AKH (including both in vitro and in vivo assays)
have demonstrated that in some cases the absence of a blocked C-
terminus is less critical (33, 51, 58), whereas other investigations
have revealed the presence of an amidated C-terminus to be
very important with poor or no responses with analogs lacking
this feature (31, 59). These observed differences in response to
key structural elements, including the normally amidated C-
terminus of AKH, may reflect the occurrence of inter- and intra-
species receptor subtypes which may be differentially sensitive
to these modifications (31, 58), and could also point to the
well documented phenomenon seen for AKH receptors that
are more promiscuous whereas others are very strict in the
structural characteristics of their particular ligand (33, 34, 59).
This latter scenario is more in-line with observations for the
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FIGURE 2 | Activity of native ACP analogs from A. aegypti and G. bimaculatus
along with selected naturally-occurring AKH decapetides tested for their
activity on the ACP receptor (ACPR) using a cell-based bioluminescent assay.
(A) Dose–response curves of natural ACP analogs and selected insect AKH
decapeptides on the A. aegypti ACPR. (B) Analysis of the mosquito ACP
receptor activation at the highest tested dose (10µM) indicating activity of
Grybi-ACP is significantly reduced as a result of the single substitution at
position two. The native Aedae-AKH along with Bommo-AKH were inactive on
A. aegpyti ACPR while Lacol-AKH and Helze-AKH showed low activity. The
half maximal effective concentration (EC50) for each analog along with the
corresponding change in activity relative to native A. aegypti ACP is provided
in Table 1. Luminescence is plotted relative to the maximal response achieved
when 10−5M Aedae-ACP was applied to the ACPR. Data represent mean ±
standard error of three independent biological replicates. In (B), different letters
denote significant difference (p < 0.01) as determined by ANOVA and
Tukey post-test.
A. aegypti ACP system where only a single functional receptor
variant occurs (27), which we show herein does not tolerate
the absence of the C-terminal amidation and is thus of high
importance for the ACP system. Thirdly, both aromatic residues
were essential for activity on the ACPRwhile N-terminal residues
of the peptide, including mainly threonine and pyroglutamic
acid, were also highly critical since alanine substitutions were
not tolerated leading to significantly reduced activity of these
analogs relative to the native ACP peptide. However, alternatively
FIGURE 3 | Dose–response curves of the native A. aegypti AKH along with
mostly naturally occurring analogs from a variety of insects that contain
substitutions or other modifications, which were tested for their activity on the
AKHR-IA receptor using a cell-based bioluminescent assay. (A) Naturally
occurring insect AKH analogs having critical substitutions that are not well
tolerated by the AKHR-IA, with moderately compromised activity relative to the
native A. aegypti AKH. (B) Naturally occurring insect AKH analogs, or a
synthetic analog (V2-Peram-CAH-II), having substitutions that are well
tolerated by the AKHR-IA, with marginally compromised or slightly improved
activity relative to the native A. aegypti AKH. The half maximal effective
concentration (EC50) for each analog along with the corresponding change in
activity relative to native A. aegypti AKH is provided in Table 2. Luminescence
is plotted relative to the maximal response achieved when 10−5M Aedae-AKH
was applied to the AKHR-IA. Data represent mean ± standard error of three
independent biological replicates.
blocking this alanine substitution on the N-terminus through
acetylation improved the activity of this analog by 10-fold.
Similar observations have been made with AKH analogs tested
using both in vivo and in vitro assays whereby complete
removal of the N-terminal pyroglutamate abolishes activity of
the AKH analog whereas the alternatively blocked N-terminus
(i.e., N-Acetyl-Ala), or even simply glutamate or glutamine
that can spontaneously undergo cyclization (60), were shown
to have improved activity, albeit lower than the native AKH
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(31, 54, 58). Interestingly, alanine substitution for valine in the
second position, thus both hydrophobic but the former having
a shorter side chain, led to a relatively minor effect on ACPR
activation (∼70-fold reduced activity). Comparatively, replacing
valine at position two with another aliphatic amino acid with a
hydrophobic but longer side chain as in Grybi-ACP (isoleucine
at position two) had only a minor effect on ACPR activation with
a ∼14-fold reduction compared to Aedae-ACP, indicating that
side chain length at this position may be important for ligand-
receptor interaction. The internally truncated analog omitting
valine within the N-terminal region elicited no ACPR activation,
indicating that the spacing between the more critical residues,
namely pyroglutamate and polar threonine, is essential for
ACP peptide activity on the ACPR. Thus, perhaps in common
with AKH structural features, the switch between adjacent
hydrophobic and hydrophilic residues is necessary in order to
properly “fit” and bind with its particular receptor (31) so that
not only is the ACP analog shorter by one amino acid (a non-
apeptide), but moreover, the entire structural configuration of
the peptide is disrupted and the whole sequence is no longer in
sync with its binding pocket on the receptor. This corroborates
with studies that have examined the conservation of the ACP
primary structures across insects from different orders (including
Diptera, Lepidoptera, Coleoptera, Hymenoptera and Hemiptera)
as well as from various species within the same order (seventeen
species of Coleoptera), where the N-terminal pentamer sequence,
when the ACP system is present, is nearly completely conserved
across these various species with a consensus motif of pQVTFS-
, whereas significant sequence variability occurs within the C-
terminus of the ACP sequence with deca-, nona- and even
dodecapeptides reported (2, 61).
Our studies on the importance of specific amino acids of the
ligand Aedae-AKH for activating the mosquito AKH receptor
were driven by a number of previous studies on AKH receptors
utilizing in vitro heterologous assays as well as in vivo bioassays
monitoring lipid- and/or carbohydrate-mobilizing actions of
AKH analogs. For instance, the blocked N- and C-termini were
mostly quite important and the aromatics at positions 4 and 8
were absolutely essential (46, 47, 53, 54). Furthermore, it was
demonstrated earlier that certain AKH receptors tested in vitro
were found to be quite promiscuous reacting well to ligands
that had many substitutions, for example the AKH receptors
from the desert locust Schistocerca gregaria and the pea aphid
Acyrthosiphon pisum (34). On the other hand, a group of AKH
receptors from other insects, including the fruit fly Drosophila
melanogaster and the mosquito A. aegypti, were found to be
highly specific, tolerating only minor substitutions (33, 34).
However, since only a few modifications to the natural AKH
ligand were tested on the A. aegypti receptor, in the present
study we focused on the importance of residues at positions
two and three at the amino end and five through seven at the
carboxyl end by utilizing naturally-occurring AKH bioanalogues
containing all or a subset of these substitutions. Starting with
Grybi-AKH, which differs from Aedae-AKH in all the variable
positions except the prototypical features of any insect AKH
such as pyroglutamic acid at the first position, phenylalanine
and tryptophan at positions four and eight, respectively, and
an amidated C-terminus, we demonstrated a large reduction
in activation of the Aedae-AKHR-IA by over three orders of
magnitude. This gave us the opportunity to tease out which of the
five positions are the main drivers for this observed low activity.
Previous studies using modifications at positions five and seven
together had shown that such ligands resulted only in a slight loss
of receptor activation (33, 34, 58). In line with this observation,
position six was not found to be essential for AKHR-IA activation
since a single amino acid change from the uniquely shaped
imino acid proline to a serine residue (as found in Hipes-AKH-
I), resulted in <10-fold loss in activity on AKHR-IA. Here, we
clearly established that position seven, although changed either
from a polar side chain in serine to a much larger polar side chain
in asparagine (Peram-CAH-II), or to the shortest amino acid
glycine (Tabat-AKH), is not essential for activation of AKHR-IA
since these analogs had comparable activity to the native Aedae-
AKH. In fact, to our surprise, Tabat-AKHmay serve as a potential
lead substance for design of a superagonist since this natural
AKH analog elicited 30% improved activity relative to the native
mosquito AKH. It appears that the more flexible and non-polar
glycine residue allows the ligand a tighter binding to the receptor
than the polar and neutral serine. This is particularly interesting
given the permissiveness of substitutions in the vicinity of the C-
terminus, whichmay allow a greater variety of lead compounds to
be designed and tested that could interfere with this neuropeptide
system and perturb its normal functioning vital for mobilizing
energy substrates in insects. Interestingly, Bommo-AKH retained
strong activity on the A. aegypti AKHR-IA, which in common
with Tabat-AKH has a glycine substitution in position seven,
but also has an extended C-terminus containing glycine and
glutamine following after tryptophan in the eighth position. This
indicates that the extended nature of this AKH ligand does not
compromise AKHR-IA activation and follows with the earlier
observations on the overall permissiveness of the C-terminal
region of the AKH ligand.
To corroborate that the substitutions in positions two to
three were of greatest importance, we examined the activity
of a natural AKH analog from L. auripennis (Libau-AKH),
whose sequence matches that of native Aedae-AKH except for
positions two to three (valine and asparagine) that are instead
shared with Grybi-AKH. Indeed, our results confirmed that
the substitutions in this N-terminal region are much more
critical and are not well tolerated by AKHR-IA in A. aegypti
since Libau-AKH displayed only a marginal improvement (i.e.,
nearly 2-fold) compared to Grybi-AKH. Supporting the notion
that N-terminal residues are most important for AKHR-IA
activation, two additional natural AKH analogs were examined
having substitutions in either the third position alone (Erysi-
AKH) or both the third and seventh position residue (Pyrap-
AKH). In comparison to Aedae-AKH, Erysi-AKH had a similar
reduction in activity as Pyrap-AKH indicating that the residue
in the third position is essential within the natural AKH ligand
since it is established that a seventh position substitution has a
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negligible effect. In light of this evidence indicating substitutions
in positions two and three are not well tolerated by the A.
aegypti AKHR-IA, we aimed to discern which of these two
sites were the absolute most critical. Comparing the activity
V2-PeramCAH-II with that of Pyrap-AKH demonstrates that the
valine substitution for leucine in the second position is far better
tolerated compared to the asparagine substitution for threonine
in the third position, indicating this latter position is indeed the
most critical.
Taken together, these finding corroborate recent analysis of
select dipteran AKH analogs where structure-activity analyses
showed the least tolerated substitutions were localized to the N-
terminal region, proving crucial for activation ofD. melanogaster
and A. gambiae AKH receptors, which the authors described
was due to this core region of the peptide forming a predicted
β -strand necessary for receptor interaction (33). Further, this
supports our findings that the C-terminal region of the AKH
octapeptide, excluding the aromatic tryptophan in the eighth
position, is not as critical for activity. As a putative reason
for this, it is argued that the side chains of a subset of these
amino acids may be buried in the assumed β-turn formed by
the residues in the C-terminal region of AKH neuropeptides
(31, 33, 46), which is now supported by molecular modeling
and nuclear magnetic resonance spectroscopy studies that have
confirmed the β-turn configuration in the AKH secondary
structure (36, 37, 62, 63). Indeed, a comprehensive structural
analysis of the AKH system in the desert locust, Scistocerca
gregaria, recently confirmed that all three of the native AKH
neuropeptides despite exhibiting differences in amino acid
composition and in the length of the peptide (i.e., both octa-
and decapeptide analogs), nonetheless exhibit a β-turn structure
and interact with the same residues within the single locust AKH
receptor (40).
Integrating the novel data from the present study analyzing
structural characteristics of the two most recently diverged
GnRH-related family members in arthropods, we can infer with
some degree of confidence how these ligands act only upon their
respective receptors. The ACP sequence in many insect species
often contain charged residues in positions six, seven or nine,
which in instances where only a single basic or acidic residue
occurs, provide an overall charge to the peptide (2, 61). However,
our results revealed that the overall charge of the ACP analog
did not largely compromise activity since alanine substitutions
of these charged residues were quite tolerated by the ACPR.
Comparatively, AKH receptors do not like charges associated
with their ligands since no basic residues occur and only a few
natural AKH family members containing an acidic residue (e.g.,
aspartic acid at position seven) are known, which have been
shown to be not well tolerated by AKH receptors in L. migratoria
and P. americana (47, 64, 65). Another feature differentiating
the AKH and ACP peptides in A. aegypti is the presence of
an alternating pattern of hydrophobic and hydrophilic residues
over the entire length of the Aedae-AKH, which is shared with
other AKH family members (31), whereas the ACP contains a
motif of three hydrophilic residues at its core residues 5–7, which
may lead to incompatability with the AKHR-IA. Additionally,
clearly the valine substitution in position two is not tolerated
well by the A. aegypti AKHR-IA, and so this residue which
is present in position two of the ACP sequence may also
contribute toward the inactivity of this peptide on the AKHR-
IA. On the other hand, since the AKH peptide from B. mori (a
decapeptide) was quite active on the A. aegypti AKHR-IA, the
longer length of ACP is unlikely to be the cause of its inactivity on
the AKHR-IA.
Our findings also set the framework toward understanding
why the A. aegypti AKH has no activity on the ACP receptor.
As we saw with the AKHR-IA, substitution of valine for leucine
in position two led to nearly a 70-fold reduction in receptor
activity. On the other hand, the removal of valine and its
replacement with alanine in the ACP sequence led to a similar 70-
fold reduction in activity on the ACPR. In contrast, substitution
of valine in position two with another branched-chain amino
acid (i.e., isoleucine) found in the Grybi-ACP analog, only
marginally reduced activity. Thus, the presence of valine in
position two is needed for optimal activity for ACPR whereas
its absence in the same position (but on the AKH peptide)
is necessary for optimal activation of AKHR-IA. Finally, one
clear finding from these studies is that ACP analogs that are
too short (nonapeptide or octapeptide), even if they contain
all the hallmark features, as demonstrated by the C-terminally
truncated analogs for example, fail to activate ACPR. Thus,
the length of the ligand is most relevant and the binding
pocket of ACPR requires at least a decapeptide leaving the
A. aegypti AKH, an octapeptide, too short for ACPR binding
and activation, while comparatively some decapeptide AKH
analogs demonstrated low (albeit significant) levels of activity
on ACPR.
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